Literature DB >> 18845285

New pelvic symptoms are common after reconstructive pelvic surgery.

Thythy Pham1, Kimberly Kenton, Elizabeth Mueller, Linda Brubaker.   

Abstract

OBJECTIVE: The objective of the study was to determine the incidence of new pelvic symptoms after reconstructive pelvic surgery and its impact on surgical outcomes. STUDY
DESIGN: Women undergoing surgery for prolapse (POP) and/or urinary incontinence underwent preoperative and 3 month postoperative assessment: urodynamics, pelvic organ prolapse quantification, and Pelvic Floor Distress Inventory (PFDI-20). Postoperative assessment included Patient Global Impression of Improvement (PGI-I), satisfaction, and new symptom questionnaire.
RESULTS: Forty-two percent (33/79) reported new pelvic symptoms: incontinence (27%), urgency (25%), frequency (23%), difficult defecation (22%), voiding difficulty (10%), and POP (2%). Women with new symptoms differed from those without: higher postoperative mean PFDI-20 scores (P < .001 for Urinary Distress Inventory, P = .02 for Pelvic Organ Prolapse Distress Inventory, and P = .02 Colorectal-Anal Inventory); 58% vs 83% improved on PGI-I, compared with 83% (P = .01); 33% vs 83% completely satisfied (P <or= .001).
CONCLUSION: Women report high rates of new pelvic symptoms after surgery, which are associated with decreased self-reported improvement and satisfaction despite improvement on validated quality of life measures.

Entities:  

Mesh:

Year:  2008        PMID: 18845285     DOI: 10.1016/j.ajog.2008.08.010

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

Review 1.  Repair of pelvic organ prolapse: what is the goal?

Authors:  Margarita M Aponte; Nirit Rosenblum
Journal:  Curr Urol Rep       Date:  2014-02       Impact factor: 3.092

2.  The impact of dispositional optimism on symptoms and treatment choices in patients with pelvic floor disorders.

Authors:  Lior Lowenstein; Olga Ramm; Elizabeth Mueller; Linda Brubaker; Mary Pat FitzGerald; Joel Lopez; Kimberly Kenton
Journal:  Int Urogynecol J       Date:  2011-09-02       Impact factor: 2.894

3.  Urinary symptoms are associated with certain urinary microbes in urogynecologic surgical patients.

Authors:  Cynthia S Fok; Xiang Gao; Huaiying Lin; Krystal J Thomas-White; Elizabeth R Mueller; Alan J Wolfe; Qunfeng Dong; Linda Brubaker
Journal:  Int Urogynecol J       Date:  2018-08-16       Impact factor: 2.894

4.  Robotics for Pelvic Reconstruction.

Authors:  Olga Ramm; Kimberly Kenton
Journal:  Curr Bladder Dysfunct Rep       Date:  2011-06-30

5.  Which factors determine subjective improvement following pelvic organ prolapse 1 year after surgery?

Authors:  Sameh S S Lawndy; Kirsten B Kluivers; Alfredo L Milani; Mariella I J Withagen; Jan C M Hendriks; Mark E Vierhout
Journal:  Int Urogynecol J       Date:  2010-11-23       Impact factor: 2.894

6.  Years from menopause-to-surgery is a major factor in the post-operative subjective outcome for pelvic organ prolapse.

Authors:  Ki Hoon Ahn; Tak Kim; Jun Young Hur; Sun Haeng Kim; Kyu Wan Lee; Young Tae Kim
Journal:  Int Urogynecol J       Date:  2010-03-23       Impact factor: 2.894

7.  Functional Outcomes for Incontinence and Prolapse Surgery.

Authors:  Saya Segal; Lily A Arya; Ariana L Smith
Journal:  Curr Bladder Dysfunct Rep       Date:  2012-09

8.  Surgical preparation: are patients "ready" for stress urinary incontinence surgery?

Authors:  L Brubaker; H J Litman; L Rickey; K Y Dyer; A D Markland; L Sirls; P Norton; E Casiano; M F R Paraiso; C Ghetti; D D Rahn; J W Kusek
Journal:  Int Urogynecol J       Date:  2013-08-03       Impact factor: 2.894

9.  Pre-operative guided imagery in female pelvic medicine and reconstructive surgery: a randomized trial.

Authors:  Elizabeth J Billquist; Aaron Michelfelder; Cynthia Brincat; Linda Brubaker; Colleen M Fitzgerald; Elizabeth R Mueller
Journal:  Int Urogynecol J       Date:  2017-09-07       Impact factor: 2.894

Review 10.  Emerging concepts for pelvic organ prolapse surgery: What is cure?

Authors:  Una Lee; Shlomo Raz
Journal:  Curr Urol Rep       Date:  2011-02       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.